Axsome Therapeutics (AXSM) EPS US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EPS, rub | ? | -3.47 | -4.60 | -5.27 | -5.99 | -3.68 | -3.68 | ||
| Changes by years, y/y, % | +25% | +33% | +14% | +14% | -39% | +5.9% | |||
Axsome Therapeutics. EPS, rub
Axsome Therapeutics. EPS, changes, %
Axsome Therapeutics (AXSM) EPS US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EPS, rub | ? | -1.22 | -0.97 | -0.94 | -0.56 | -1.26 | -3.68 | |
| Changes by years, y/y, % | -16% | -42% | -30% | -63% | +4% | |||
| Changes by quarters, q/q, % | -21% | -20% | -3% | -40% | +123% | |||